Advertisement
Screener

Indaptus Therapeutics, Inc. (INDP) ROA

Indaptus Therapeutics, Inc. (INDP) ROA

  • 2026-06-30: ROA -128.66%.
  • 2025-12-31: ROA -223.94%.
  • 2025-09-30: ROA -246.60%.
  • 2025-06-30: ROA -248.00%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-128.66%
2025-12-31-223.94%
2025-09-30-246.60%
2025-06-30-248.00%
2025-03-31-291.00%
2024-12-31-204.69%
2024-09-30-180.75%
2024-06-30-193.89%
2024-03-31-136.79%
2023-12-31-103.35%
2023-09-30-84.73%
2023-06-30-70.14%
2023-03-31-65.72%
2022-12-31-51.04%
2022-09-30-45.59%
2022-06-30-40.47%
2022-03-31-28.22%
2021-12-31-19.00%
2021-09-30-12.00%
2021-06-30-17.13%
2020-12-31-201.61%

Annual ROA

DateROA
2025-12-31-223.94%
2024-12-31-204.69%
2023-12-31-103.35%
2022-12-31-51.04%
2021-12-31-19.00%
2020-12-31-201.61%

Similar stocks

Stock NameCountryMarket CapPE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82